U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
146611146611Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeActive, not recruitingHas ResultsMalignant Neoplasms of BrainBiological: PEP-3 vaccine|Biological: sargramostim|Drug: Temozolomidehttps://ClinicalTrials.gov/show/NCT00643097
146612146612Bowel Prep vs Non-Bowel Prep for Laparoscopic Colorectal SurgeryNot yet recruitingNo Results AvailableAnastomotic Leak|Surgical Site InfectionProcedure: low residue diet/no standard bowel preparation|Procedure: standard bowel preparationhttps://ClinicalTrials.gov/show/NCT00643084
146613146613Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis PatientsCompletedNo Results AvailableUlcerative ColitisDrug: Tacrolimushttps://ClinicalTrials.gov/show/NCT00643071
146614146614Nitric Oxide, LPS and the Pathogenesis of Asthma Phase IITerminatedNo Results AvailableHealthyBiological: LPS endotoxinhttps://ClinicalTrials.gov/show/NCT00643058
146615146615Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine AgonistCompletedNo Results AvailableIdiopathic Parkinson's DiseaseDrug: Safinamide|Drug: Safinamide|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00643045
146616146616Preoperative Anxiety and Postoperative Pain in ChildrenNot yet recruitingNo Results AvailablePost-Operative Pain|Pre-Operative AnxietyProcedure: Transcutaneous iliohypogastric|Procedure: Perioperative administration near the nervehttps://ClinicalTrials.gov/show/NCT00643032
146617146617Project Sexual Awareness for Everyone (SAFE)CompletedNo Results AvailableSexually Transmitted Disease|Secondary Prevention|Behavioral Modification|Public HealthBehavioral: SAFE Behavioral Intervention|Other: Controlhttps://ClinicalTrials.gov/show/NCT00643019
146618146618Physical Exercise and Its Impact on Signs of Inflammation in FibromyalgiaCompletedHas ResultsExercise Therapy|PainBehavioral: Physical exercise|Behavioral: Active comparator: low intensive exercisehttps://ClinicalTrials.gov/show/NCT00643006
146619146619Efficacy and Safety Trial to Evaluate the Effect of SCH 497079 on Weight in Obese and Overweight Subjects (Study P05483)(COMPLETED)CompletedNo Results AvailableObesity|Overweight|Body WeightDrug: SCH 497079|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00642993
146620146620Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial VaginosisCompletedNo Results AvailablePregnancyDrug: Clindamycin|Drug: Placebo|Drug: Clindamycinhttps://ClinicalTrials.gov/show/NCT00642980
146621146621A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on DialysisCompletedNo Results AvailableAnemiaDrug: methoxy polyethylene glycol-epoetin beta [Mircera]https://ClinicalTrials.gov/show/NCT00642967
146622146622Vorinostat (MK-0683, SAHA [Suberoylanilide Hydroxamic Acid]) + Lenalidomide + Dexamethasone in Multiple Myeloma (MM) (MK-0683-074)CompletedNo Results AvailableRelapsed or Refractory Multiple MyelomaDrug: Comparator: vorinostat|Drug: Comparator: lenalidomide|Drug: Comparator: dexamethasonehttps://ClinicalTrials.gov/show/NCT00642954
146623146623A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.CompletedNo Results AvailableSarcomaDrug: RG1507https://ClinicalTrials.gov/show/NCT00642941
146624146624Dose Range Finding Study of BF2.649 Versus Placebo to Treat Excessive Daytime Sleepiness in Parkinson's Disease PatientsCompletedNo Results AvailableExcessive Daytime Sleepiness|Parkinson's DiseaseDrug: Placebo|Drug: BF 2.649 5 mg|Drug: BF 2.649 10 mg|Drug: BF 2.649 20 mg|Drug: BF 2.649 40 mghttps://ClinicalTrials.gov/show/NCT00642928
146625146625Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)CompletedNo Results AvailableDiabetes MellitusDrug: Lantus, Amarylhttps://ClinicalTrials.gov/show/NCT00642915
146626146626Atacicept in Multiple Sclerosis, Phase IITerminatedNo Results AvailableRelapsing Multiple SclerosisDrug: atacicept|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00642902
146627146627Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist (12 Month Extension)CompletedNo Results AvailableParkinson's DiseaseDrug: Safinamide|Drug: Safinamide|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00642889
146628146628PRESTIGE® Cervical Disc StudyCompletedNo Results AvailableDegenerative Cervical Disc DiseaseDevice: Allograft Fusion and ATLANTIS™ Cervical Plate System|Device: PRESTIGE® Cervical Dischttps://ClinicalTrials.gov/show/NCT00642876
146629146629Brain and Behavior Depending on Timing of Iron Deficiency in Human InfantsCompletedNo Results AvailableIron Deficiency|Iron Deficiency AnemiaDietary Supplement: Ferrous Sulfate (liquid) + vitamins A and D|Dietary Supplement: vitamins A and D|Dietary Supplement: Ferrous sulfate (liquid)https://ClinicalTrials.gov/show/NCT00642863
146630146630STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis PatientsCompletedNo Results AvailableAnemiaDrug: methoxy polyethylene glycol-epoetin beta [Mircera]https://ClinicalTrials.gov/show/NCT00642850
146631146631A Study on Health - Related Quality of Life in Patients With Rheumatic Diseases Taking Tramadol 37.5mg/Acetaminophen 325mg TabletsCompletedNo Results AvailableRheumatic DiseasesDrug: Tramadol/acetaminophen|Drug: Tramadol/acetaminophen|Drug: Tramadol/acetaminophen|Drug: Tramadol/acetaminophen|Drug: Tramadol/acetaminophen|Drug: Tramadol/acetaminophen|Drug: Tramadol/acetaminophen|Drug: Tramadol/acetaminophen|Drug: Tramadol/acetaminophen|Drug: Tramadol/acetaminophenhttps://ClinicalTrials.gov/show/NCT00642837
146632146632A Genetic Substudy Associated With the Avastin (Bevacizumab) Study MO19390 in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.TerminatedNo Results AvailableNon-Squamous Non-Small Cell Lung CancerDrug: Standard chemotherapy|Drug: bevacizumab [Avastin]https://ClinicalTrials.gov/show/NCT00642824
146633146633A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-respondersCompletedHas ResultsStable Coronary Artery DiseaseDrug: Ticagrelor|Drug: Clopidogrel|Drug: Aspirinhttps://ClinicalTrials.gov/show/NCT00642811
146634146634An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects (0431-108)(COMPLETED)CompletedNo Results AvailableDiabetes Mellitus Non-insulin-dependentDrug: sitagliptin phosphatehttps://ClinicalTrials.gov/show/NCT00642798
146635146635Activation of Alternative Cellular Energy (ACE) Pathway in the Therapy of Herpes Virus InfectionsCompletedNo Results AvailableHerpes Simplex|Herpes Zosterhttps://ClinicalTrials.gov/show/NCT00642785
146636146636Group Physical Therapy for Knee OsteoarthritisCompletedHas ResultsOsteoarthritisOther: Group Physical Therapyhttps://ClinicalTrials.gov/show/NCT00642772
146637146637Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung CancerCompletedNo Results AvailableNon-small Cell Lung CancerDrug: carboplatin|Drug: Abraxane|Drug: Bevacizumabhttps://ClinicalTrials.gov/show/NCT00642759
146638146638Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)TerminatedHas ResultsMetastatic Colorectal CancerDrug: Erlotinib|Drug: Fluorouracil|Drug: Leucovorin|Drug: Oxaliplatin|Drug: Irinotecanhttps://ClinicalTrials.gov/show/NCT00642746
146639146639A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic CancerTerminatedNo Results AvailablePancreatic CancerDrug: erlotinib [Tarceva]|Drug: gemcitabinehttps://ClinicalTrials.gov/show/NCT00642733
146640146640Change in Quality of Life After Addition of Weekly 40 mg Pegvisomant/Placebo in Controlled Acromegalic PatientsCompletedNo Results AvailableQuality of Life|AcromegalyDrug: Pegvisomanthttps://ClinicalTrials.gov/show/NCT00642720

* Görseller ve İçerik tekif hakkına sahip olabilir